Biotech - Spark Newswire

3 minute read

Albireo Pharma Highlights Presentation Of Data From Phase 3 PEDFIC Study

Today, 3:25 AM

Albireo Pharma, Inc. (NASDAQ:ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today presented clinical data from its Phase 3 PEDFIC 1 study and an interim data cut of the

ALBO

1 minute read

Valneva Concludes Recruitment for COVID-19 Vaccine Candidate Trial

By Vandana Singh

Today, 3:25 AM

Privately-held Valneva SE has completed recruitment for the pivotal Phase 3 trial of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. VLA2001…

AZN

1 minute read

Bayer Buys Two Biotech Firms to Beef Up Radiopharmaceuticals

By Vandana Singh

Today, 3:25 AM

Bayer AG (OTC:BAYRY) will acquire two small biotech companies in a deal that adds an experimental prostate cancer medicine to the…

BAYRY

1 minute read

Novartis’ Prostate Cancer Radioligand Therapy Extended Overall Survival by Four Months

By Vandana Singh

Today, 3:25 AM

Novartis AG (NYSE:NVS) has announced results from Phase 3 VISION study evaluating 177Lu-PSMA-617, a targeted radioligand therapy, plus best standard of…

NVS

1 minute read

Bristol Myers Faces $6.4B Lawsuit Over Delayed Approval of Breyanzi Non-Hodgkin Lymphoma Drug: Reuters

By Vandana Singh

Today, 3:25 AM

Bristol Myers Squibb Co (NYSE:BMY) was sued for $6.4 billion for allegedly delaying approval for Breyanzi cancer drug to avoid payments…

BMY

2 minute read

Why Adamis Shares Are Ripping Higher Today

By Shanthi Rexaline

Today, 3:25 AM

Shares of Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) spiked higher in afternoon trading Thursday following some positive tidings on one of its pipeline assets.

ADMP

2 minute read

Could Clovis Oncology Stock Be Gearing Up For Its Next Move?

By Tyler Bundy

Today, 3:25 AM

Clovis Oncology Inc. (NASDAQ: CLVS) is gearing up to present this week at the American Society of Clinical Oncology annual meeting, which runs June 4-8. The company is expected to report updated Phase 1b results on Lucitanib and Opdivo in patients with advanced solid tumors.

CLVS

1 minute read

Adamas Shares Moving On Report National Institutes For Health Says Co.’s Drug Tempol Could Be ‘Promising Oral Antiviral Treatment’ For COVID-19

By Benzinga Newsdesk

Today, 3:25 AM

-Bloomberg

ADMP

4 minute read

FDA
News

Ascendis Pharma’s VISEN Says Has Received Investigational New Drug Approval From Center For Drug Evaluation Of National Medical Products Administration For Phase 3 China Clinical Trial Of TransCon PTH Solution For Injection

By Benzinga Newsdesk

Today, 3:25 AM

The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial 1. VISEN Pharmaceuticals has obtained the investigational new drug (IND) approval from the Center

ASND

2 minute read

Actinium Pharmaceuticals Details SIERRA at Benzinga Global Small Cap Business Conference

By M.J. Walker

Today, 3:25 AM

Actinium Pharmaceuticals Inc. (NYSE: ATNM), a clinical-stage biopharmaceutical company that develops antibody radiation-conjugates (ARC), took part in the Benzinga Global Small Cap Business Conference on May 13, 2021.

ATNM